Debt-to-equity of ARTELO BIOSCIENCES, INC. from 31 May 2016 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
ARTELO BIOSCIENCES, INC. quarterly Debt-to-equity in % history and change rate from 31 May 2016 to 31 Dec 2025.
  • ARTELO BIOSCIENCES, INC. Debt-to-equity for the quarter ending 31 Dec 2025 was -662%, a 3966% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

ARTELO BIOSCIENCES, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 -662% -679% -3966% 31 Dec 2025
Q3 2025 1045% +1034% +9244% 30 Sep 2025
Q2 2025 133% +123% +1314% 30 Jun 2025
Q1 2025 38% +31% +443% 31 Mar 2025
Q4 2024 17% +11% +182% 31 Dec 2024
Q3 2024 11% +6.2% +124% 30 Sep 2024
Q2 2024 9.4% +5.4% +137% 30 Jun 2024
Q1 2024 7% +3.4% +96% 31 Mar 2024
Q4 2023 6.1% +2.8% +83% 31 Dec 2023
Q3 2023 5% +1.9% +60% 30 Sep 2023
Q2 2023 4% +0.38% +10% 30 Jun 2023
Q1 2023 3.6% 31 Mar 2023
Q4 2022 3.3% 31 Dec 2022
Q3 2022 3.1% 30 Sep 2022
Q2 2022 3.6% 30 Jun 2022
Q2 2017 -262% -1238% -127% 31 May 2017
Q1 2017 -149% 28 Feb 2017
Q4 2016 -142% 30 Nov 2016
Q3 2016 -155% 31 Aug 2016
Q2 2016 977% 31 May 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.